GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MyunMoon Pharm Co Ltd (XKRX:017180) » Definitions » EV-to-Revenue

MyunMoon Pharm Co (XKRX:017180) EV-to-Revenue : 0.86 (As of May. 30, 2024)


View and export this data going back to 2008. Start your Free Trial

What is MyunMoon Pharm Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MyunMoon Pharm Co's enterprise value is ₩150,262 Mil. MyunMoon Pharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩173,796 Mil. Therefore, MyunMoon Pharm Co's EV-to-Revenue for today is 0.86.

The historical rank and industry rank for MyunMoon Pharm Co's EV-to-Revenue or its related term are showing as below:

XKRX:017180' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.88   Med: 1.38   Max: 3.56
Current: 0.86

During the past 13 years, the highest EV-to-Revenue of MyunMoon Pharm Co was 3.56. The lowest was 0.88. And the median was 1.38.

XKRX:017180's EV-to-Revenue is ranked better than
82.78% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 2.265 vs XKRX:017180: 0.86

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-30), MyunMoon Pharm Co's stock price is ₩2050.00. MyunMoon Pharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩5,186.47. Therefore, MyunMoon Pharm Co's PS Ratio for today is 0.40.


MyunMoon Pharm Co EV-to-Revenue Historical Data

The historical data trend for MyunMoon Pharm Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyunMoon Pharm Co EV-to-Revenue Chart

MyunMoon Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.55 2.62 1.74 1.16 0.95

MyunMoon Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 1.03 0.94 0.95 0.94

Competitive Comparison of MyunMoon Pharm Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, MyunMoon Pharm Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MyunMoon Pharm Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MyunMoon Pharm Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where MyunMoon Pharm Co's EV-to-Revenue falls into.



MyunMoon Pharm Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

MyunMoon Pharm Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=150261.658/173795.737
=0.86

MyunMoon Pharm Co's current Enterprise Value is ₩150,262 Mil.
MyunMoon Pharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩173,796 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MyunMoon Pharm Co  (XKRX:017180) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

MyunMoon Pharm Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2050.00/5186.468
=0.40

MyunMoon Pharm Co's share price for today is ₩2050.00.
MyunMoon Pharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,186.47.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MyunMoon Pharm Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of MyunMoon Pharm Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MyunMoon Pharm Co (XKRX:017180) Business Description

Traded in Other Exchanges
N/A
Address
946-18 Dokok-Dong, Kangnam-ku, Seoul, KOR, 135-270
MyunMoon Pharm Co Ltd is a South Korea based company engages in the manufacture and sale of pharmaceutical products. Its products include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs, and others.

MyunMoon Pharm Co (XKRX:017180) Headlines

No Headlines